This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

AMAG Pharmaceuticals Inc (AMAG)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash and Equivalents 26.99M 46.29M 63.47M 112.65M
Receivables 7.12M 6.67M 6.36M 6.23M
Inventories 17.22M 12.45M 15.21M 16.34M
Other Current Assets 0.00 2.00M 0.00 0.00
Total Current Assets 244.40M 254.38M 240.03M 290.78M
Property, Plant & Equipment, Gross 2.34M 11.04M 24.80M 24.29M
Accumulated Depreciation & Depletion 496.00K 7.74M 15.59M 13.06M
Property, Plant & Equipment, Net 1.85M 3.30M 9.21M 11.24M
Intangibles 16.84M 0.00 0.00 0.00
Other Non-Current Assets 2.36M 460.00K 17.99M 34.06M
Total Non-Current Assets 21.05M 3.76M 27.19M 45.29M
Liabilities & Shareholder Equity
Total Assets 265.46M 258.14M 267.22M 336.08M
Accounts Payable 2.63M 3.52M 3.73M 4.55M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 33.12M 32.96M 38.99M 36.71M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 2.03M 0.00 2.79M
Other Non-Current Liabilities 59.93M 50.35M 47.63M 51.29M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 59.93M 52.38M 47.63M 54.08M
Total Liabilities 93.05M 85.34M 86.63M 90.79M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 172.41M 172.80M 180.60M 245.29M
Common Par 218.00K 215.00K 213.00K 211.00K
Additional Paid In Capital 641.94M 632.49M 625.13M 614.94M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -466.26M -456.66M -439.91M -362.84M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -3.49M -3.25M -4.84M -7.03M
Total Capitalization 172.41M 172.80M 180.60M 245.29M
Total Equity 172.41M 172.80M 180.60M 245.29M
Total Liabilities & Stock Equity 265.46M 258.14M 267.22M 336.08M
Total Common Shares Outstanding 21.77M 21.51M 21.31M 21.14M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 21.70M 21.39M 21.19M 20.81M
Diluted Weighted Shares Outstanding 21.70M 21.39M 21.19M 20.81M
Number of Employees 148 129 174 226
Number of Part-Time Employees 0 0 0 0

AMAG AMAG Pharmaceuticals Inc

Analysts Ratings for AMAG

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 4 4 4
Moderate Buy 0 0 0 0
Hold 2 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

Brokerage Partners

AMAG Chatter

Select the service that is right for you!

Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs